---
document_datetime: 2025-01-09 10:24:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/palforzia-epar-all-authorised-presentations_en.pdf
document_name: palforzia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7312162
conversion_datetime: 2025-12-22 14:10:22.651289
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/20/1495/001   | Palforzia   | 0.5 mg / 1 mg   | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 13 capsules (2 x 0.5 mg + 11 x 1 mg)   |
|--------------------|-------------|-----------------|---------------------------------------|------------|---------------------------------------------|----------------------------------------|
| EU/1/20/1495/002   | Palforzia   | 1 mg            | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 48 capsules                            |
| EU/1/20/1495/003   | Palforzia   | 1 mg            | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 96 capsules                            |
| EU/1/20/1495/004   | Palforzia   | 1 mg / 10 mg    | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 48 capsules (32 x 1 mg + 16 x 10 mg)   |
| EU/1/20/1495/005   | Palforzia   | 20 mg           | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 16 capsules                            |
| EU/1/20/1495/006   | Palforzia   | 20 mg           | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 32 capsules                            |
| EU/1/20/1495/007   | Palforzia   | 20 mg           | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 64 capsules                            |
| EU/1/20/1495/008   | Palforzia   | 20 mg / 100 mg  | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 32 capsules (16 x 20 mg + 16 x 100 mg) |
| EU/1/20/1495/009   | Palforzia   | 20 mg / 100 mg  | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 64 capsules (48 x 20 mg + 16 x 100 mg) |
| EU/1/20/1495/010   | Palforzia   | 20 mg / 100 mg  | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 64 capsules (32 x 20 mg + 32 x 100 mg) |
| EU/1/20/1495/011   | Palforzia   | 100 mg          | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 32 capsules                            |
| EU/1/20/1495/012   | Palforzia   | 300 mg          | Oral powder in sachet                 | Oral use   | sachet (PET/alu/mLLDPE foil)                | 15 sachets                             |
| EU/1/20/1495/013   | Palforzia   | 300 mg          | Oral powder in sachet                 | Oral use   | sachet (PET/alu/mLLDPE foil)                | 30 sachets                             |
| EU/1/20/1495/014   | Palforzia   | 1 mg            | Oral powder in capsules for opening   | Oral use   | capsule (HPMC) in blister (PVC/PCTFE/alu)   | 16 capsules                            |